Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer

作者
G. Fleischhack
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:47 (6): 841-853 被引量:92
标识
DOI:10.1093/jac/47.6.841
摘要

This trial assessed the efficacy and safety of meropenem versus ceftazidime as empirical monotherapy for febrile neutropenia in paediatric cancer patients. In a prospective randomized study, 172 evaluable febrile episodes in the meropenem arm and 170 episodes in the ceftazidime arm were analysed for the clinical and microbiological response dependent on the kind of infection. About half the episodes were classified as fever of unknown origin (FUO) and the remainder as microbiologically or clinically documented infections. The most frequently documented infections in both arms were bacteraemias (22.1 versus 26.5%), predominantly caused by Gram-positive organisms (57.9 versus 71.1%). The success rate of the initial monotherapy differed significantly between the two arms and was 55.8% in the meropenem and 40.0% in the ceftazidime arm (P = 0.003). In addition, a significantly longer duration of fever and of antimicrobial therapy was observed in the ceftazidime arm than in the meropenem arm (median 5 versus 4 days, P = 0.022, and 7 versus 6 days, P = 0.009, respectively). With respect to the kind of infection, differences between the two arms were significant only in episodes classified as FUO but not in documented infections. In both arms, side effects were minimal. Despite the greater response rate for meropenem in FUO, the fact that ceftazidime has been proven to be as effective as meropenem in documented infections in the present study suggests that both drugs are useful as empirical monotherapy in febrile paediatric cancer patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Nihai发布了新的文献求助10
刚刚
刚刚
刚刚
亦木澜完成签到,获得积分10
1秒前
科研通AI65的应助被刘mm采纳,获得10
2秒前
金秋时节雨纷纷完成签到,获得积分10
2秒前
JULIE发布了新的文献求助10
2秒前
3秒前
潇洒依白完成签到,获得积分10
3秒前
甜美虔纹发布了新的文献求助10
3秒前
云泪天痕的应助被zvvZB采纳,获得10
4秒前
ru发布了新的文献求助10
5秒前
5秒前
Sherlock完成签到,获得积分10
6秒前
科研通AI6.3的应助被yun采纳,获得30
6秒前
6秒前
7秒前
ll完成签到,获得积分10
7秒前
8秒前
丁驰发布了新的文献求助10
9秒前
上官若男的应助被正直的夏蓉采纳,获得10
9秒前
GIN的应助被cc采纳,获得10
10秒前
Ava的应助被王硕采纳,获得10
10秒前
Ava的应助被羽过天晴采纳,获得10
10秒前
LY发布了新的文献求助10
11秒前
华无剑的应助被BIGDUCK采纳,获得10
12秒前
12秒前
可乐要加冰完成签到,获得积分10
12秒前
在水一方的应助被huhuh采纳,获得10
13秒前
西西完成签到 ,获得积分10
13秒前
14秒前
14秒前
14秒前
王优秀完成签到,获得积分10
14秒前
sherlock发布了新的文献求助10
14秒前
15秒前
15秒前
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192841
求助须知:如何正确求助?哪些是违规求助? 9579236
关于积分的说明 21864289
捐赠科研通 7792410
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483927